Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brusko

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Diabetes/Metabolism Research and Reviews|October 27, 2023
Diabetes Study of Children of Diverse Ethnicity and Race: Study designMaria J Redondo, Kylie K Harrall, Deborah H Glueck, et al.
Research Square|February 13, 2023
DHCR7 Expression Predicts Poor Outcomes and Mortality from SepsisFaheem W Guirgis, Vinitha Jacob, Dongyuan Wu, et al.
Frontiers in Immunology|June 30, 2017
<i>Lactobacillus johnsonii</i> N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy AdultsGuillermo E Marcial, Amanda L Ford, Michael J Haller, et al.
Critical Care Explorations|June 19, 2023
<i>DHCR7</i> Expression Predicts Poor Outcomes and Mortality From SepsisFaheem W Guirgis, Vinitha Jacob, Dongyuan Wu, et al.
Critical Care (London, England)|September 18, 2021
A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomesFaheem W Guirgis, Lauren Page Black, Morgan Henson, et al.
JCI Insight|December 13, 2016
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetesHoward R Seay, Erik Yusko, Stephanie J Rothweiler, et al.
Cell Reports|March 24, 2026
Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetesMiguel A Medina-Serpas, Maigan Brusko, Gregory J Golden, et al.
Journal of Autoimmunity|February 10, 2020
Innate inflammation drives NK cell activation to impair Treg activityJoseph W Dean, Leeana D Peters, Christopher A Fuhrman, et al.
Diabetes|September 28, 2016
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 DiabetesMichael J Haller, Stephen E Gitelman, Peter A Gottlieb, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Diabetes/Metabolism Research and Reviews|October 27, 2023
Diabetes Study of Children of Diverse Ethnicity and Race: Study designMaria J Redondo, Kylie K Harrall, Deborah H Glueck, et al.
Research Square|February 13, 2023
DHCR7 Expression Predicts Poor Outcomes and Mortality from SepsisFaheem W Guirgis, Vinitha Jacob, Dongyuan Wu, et al.
Frontiers in Immunology|June 30, 2017
<i>Lactobacillus johnsonii</i> N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy AdultsGuillermo E Marcial, Amanda L Ford, Michael J Haller, et al.
Critical Care Explorations|June 19, 2023
<i>DHCR7</i> Expression Predicts Poor Outcomes and Mortality From SepsisFaheem W Guirgis, Vinitha Jacob, Dongyuan Wu, et al.
Critical Care (London, England)|September 18, 2021
A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomesFaheem W Guirgis, Lauren Page Black, Morgan Henson, et al.
JCI Insight|December 13, 2016
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetesHoward R Seay, Erik Yusko, Stephanie J Rothweiler, et al.
Cell Reports|March 24, 2026
Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetesMiguel A Medina-Serpas, Maigan Brusko, Gregory J Golden, et al.
Journal of Autoimmunity|February 10, 2020
Innate inflammation drives NK cell activation to impair Treg activityJoseph W Dean, Leeana D Peters, Christopher A Fuhrman, et al.
Diabetes|September 28, 2016
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 DiabetesMichael J Haller, Stephen E Gitelman, Peter A Gottlieb, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Pageof 16